QA: Cingulate Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001862150_2023_Cingulate_Inc.pdf

Logs

warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001862150', 'EntityCommonStockSharesOutstanding': 11309412, 'Assets': 11405057, 'AssetsCurrent': 7869652, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 7523035, 'LiabilitiesAndStockholdersEquity': 11405057, 'LiabilitiesCurrent': 7012800, 'LiabilitiesNoncurrent': 510235, 'NetIncome': -17676232, 'PropertyPlantAndEquipmentNet': 2904787, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 630618, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 3882022, 'remainder_NetIncome': -17676232, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001862150')"}

Edgar->Model Mapping